Code
MOG-BCIP-01AX
Test
Active-Compendium
Please contact Biotheranostics, Inc. at 877-886-6739.
Clinical
Oncology,Pathology
Testing is performed on breast primary invasive tumor.
FFPE tissue: Paraffin block is preferred. Alternatively, send 3-4 unstained, 10 micron thick sections on glass slides (an area of tumor that contains ≥40% neoplastic cells) and one H&E-stained slide.
Note: Cases with the following clinical or specimen characteristics are not acceptable: post-treatment (adjuvant or neoadjuvant) specimens, fine needle aspirations (FNA), fresh or frozen tissue, both ER- and PR-, positive nodes, microinvasive carcinoma, metaplastic or metastatic breast cancer, carcinosarcoma, sarcoma, neuroendocrine carcinoma, adenoid cystic carcinoma, phyllodes tumor, male gender, T4 tumor, no evidence of invasive (ductal, lobular or mixed ductal lobular) carcinoma, biopsy site of chest wall, skin, axilla or lymph node.
FFPE tissue: Paraffin block is preferred. Alternatively, send 3-4 unstained, 10 micron thick sections on glass slides (an area of tumor that contains ≥40% neoplastic cells) and one H&E-stained slide.
Note: Cases with the following clinical or specimen characteristics are not acceptable: post-treatment (adjuvant or neoadjuvant) specimens, fine needle aspirations (FNA), fresh or frozen tissue, both ER- and PR-, positive nodes, microinvasive carcinoma, metaplastic or metastatic breast cancer, carcinosarcoma, sarcoma, neuroendocrine carcinoma, adenoid cystic carcinoma, phyllodes tumor, male gender, T4 tumor, no evidence of invasive (ductal, lobular or mixed ductal lobular) carcinoma, biopsy site of chest wall, skin, axilla or lymph node.
Flag Active
True
Orderable Test Description
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true" data-pm-slice="1 1 []">NeoGenomics has partnered with Biotheranostics, a Hologic Company, to make ordering BCI easy for women with early-stage hormone receptor-positive (HR+) breast cancer. BCI is the only test recognized by the NCCN® Guidelines to predict which patients are likely to benefit from extended adjuvant anti-estrogen therapy beyond 5 years.</p>
Orderable Turn Around Time
7 to 10 Days
Keywords
Extra Note
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.
NY Approved
True
Orderable Biomarkers JSON
{"Polymerase Chain reaction (PCR)": {"Expression Ratio": ["HOXB13:IL17BR"], "Average Expression": ["PRM2", "RACGAP1", "NEK2", "CENPA", "BUB1B"]}}
Keywords string
HR+, Biotheranostics, early breast cancer, extended endocrine therapy, endocrine benefit, gene expression, GEP, BCI Prognostic, BCI Predictive, ER+, PR+, HR+ Breast Cancer Index® (BCI)
Title URL
breast-cancer-index-bci